- Ipsen to buy Swiss biotech Memo Therapeutics in potential $800M deal<figure><div><img src="https://imgproxy.divecdn.com/rFr9RThJC2782402VMoj7B8WOeODiV2bfIpEN0A2SvU/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS84LmpwZw==.webp"/></div></figure><p…BioPharma Dive · 26d ago↗ source
- STAT+: Pharmalittle: We’re reading about Anthropic drug development goals, Trump drug plan snags, and moreAnthropic announced the availability of Claude Science, which optimizes its large language model for use in scientific labs and by drugmakersSTAT · 26d ago↗ source
- STAT+: More signs that GLP-1s may help with peripheral artery diseaseAnthropic will begin developing drugs, BridgeBio pockets a billion, and more biotech news from The Readout